Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

NEXT STORY
HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference
PREV STORY
1Life Healthcare (One Medical) Announces Proposed Private Offering of $250 Million of Convertible Senior Notes Due 2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

NEXT STORY
HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference
PREV STORY
1Life Healthcare (One Medical) Announces Proposed Private Offering of $250 Million of Convertible Senior Notes Due 2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Viral Antigens Market is Projected to Reach US$ 236.80 Million by 2027

author_avatar
NASDAQ Market News

Jordan Barnett, M.D., is Honored by the American Health Council for Best in Medicine

NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- With a diverse educational background in ...

author_avatar
NASDAQ Market News

KetoGO Reviews – Do Nature Slim Keto GO Diet Pills Work for Weight Loss?

author_avatar
NASDAQ Market News